Calanolide A (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Calanolide A" in English language version.

refsWebsite

Global rank English rank

13web.archive.org

1^st place

9nih.gov

4^th place

7doi.org

2^nd place

2craunresearch.com.my

low place

1sarawak.gov.my

low place

1jstor.org

26^th place

20^th place

1cbd.int

6,554^th place

5,474^th place

1nytimes.com

7^th place

1independent.co.uk

36^th place

33^rd place

1sbc.org.my

low place

150megs.com

low place

8,191^st place

1sec.gov

572^nd place

436^th place

1bloomberg.com

99^th place

77^th place

1nova.my

low place

1thestar.com.my

574^th place

425^th place

1theborneopost.com

5,133^rd place

3,491^st place

1indianjournals.com

low place

1worldcat.org

5^th place

50megs.com

brimas.www1.50megs.com

Ruff AM (14 June 2001). "From the jungle to the clinic". Borneo Resources Institute. Archived from the original on 15 August 2001. Retrieved 26 October 2019.

bloomberg.com

"Company Overview of Sarawak MediChem Pharmaceuticals Inc". Bloomberg. Archived from the original on 27 May 2018. Retrieved 27 May 2018.

cbd.int

Ten KK, Wells A. Benefit-sharing case study - The access and benefit-sharing policies of the United States National Cancer Institute: a comparative account of the discovery and development of the drugs Calanolide and Topotecan (PDF). Convention of Biological Diversity. pp. 3–5. Archived from the original (PDF) on 8 December 2017. Retrieved 27 May 2018.

craunresearch.com.my

"Message From Our CEO". Craun Research Sdn Bhd. Archived from the original on 31 July 2017. Retrieved 27 May 2018.
"About Us - Calanolide A project". Archived from the original on 2 October 2022. Retrieved 2 October 2022.

doi.org

Flavin MT, Rizzo JD, Khilevich A, Kucherenko A, Sheinkman AK, Vilaychack V, et al. (March 1996). "Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers". Journal of Medicinal Chemistry. 39 (6): 1303–1313. doi:10.1021/jm950797i. PMID 8632437.
Fuller RW, Bokesch HR, Gustafson KR, McKee TC (25 August 1994). "HIV-inhibitory coumarins from latex of the tropical rainforest tree Calophyllum teysmannii var. inophylloide". Bioorganic & Medicinal Chemistry Letters. 4 (16): 1961–1964. doi:10.1016/S0960-894X(01)80543-6.
Nahar L, Talukdar AD, Nath D, Nath S, Mehan A, Ismail FM, Sarker SD (October 2020). "Naturally Occurring Calanolides: Occurrence, Biosynthesis, and Pharmacological Properties Including Therapeutic Potential". Molecules. 25 (21): 4983. doi:10.3390/molecules25214983. PMC 7663239. PMID 33126458.
Wu X, Zhang Q, Guo J, Jia Y, Zhang Z, Zhao M, et al. (19 July 2017). "Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol". Frontiers in Pharmacology. 8 (479): 479. doi:10.3389/fphar.2017.00479. PMC 5515859. PMID 28769808.
Jain MS, Barhate SD, Gayakwad BP (2018). "Calanolide A New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI): A Review". Asian Journal of Pharmaceutical Research. 8 (4): 241. doi:10.5958/2231-5691.2018.00041.2. ISSN 2231-5683.
Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT (March 2004). "Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis". Bioorganic & Medicinal Chemistry. 12 (5): 1199–1207. doi:10.1016/j.bmc.2003.11.012. PMID 14980631.
Creagh T, Ruckle JL, Tolbert DT, Giltner J, Eiznhamer DA, Dutta B, et al. (May 2001). "Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects". Antimicrobial Agents and Chemotherapy. 45 (5). American Society for microbiology: 1379–1386. doi:10.1128/AAC.45.5.1379-1386.2001. PMC 90477. PMID 11302799. Taken together, the above data demonstrate that the favorable safety profile, ...

independent.co.uk

Parry RL (1 August 2001). "Bio-pirates raid trees in the swamps of Borneo". The Independent (UK). Archived from the original on 27 May 2018. Retrieved 27 May 2018.

indianjournals.com

Jain MS, Barhate SD, Gayakwad BP (2018). "Calanolide A New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI): A Review". Asian Journal of Pharmaceutical Research. 8 (4): 241. doi:10.5958/2231-5691.2018.00041.2. ISSN 2231-5683.

jstor.org

Wilson EO (2002). "What Is Nature Worth?". Wilson Quarterly. 26 (1): 36–37. JSTOR 40260568.

nih.gov

pubmed.ncbi.nlm.nih.gov

Flavin MT, Rizzo JD, Khilevich A, Kucherenko A, Sheinkman AK, Vilaychack V, et al. (March 1996). "Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers". Journal of Medicinal Chemistry. 39 (6): 1303–1313. doi:10.1021/jm950797i. PMID 8632437.
Nahar L, Talukdar AD, Nath D, Nath S, Mehan A, Ismail FM, Sarker SD (October 2020). "Naturally Occurring Calanolides: Occurrence, Biosynthesis, and Pharmacological Properties Including Therapeutic Potential". Molecules. 25 (21): 4983. doi:10.3390/molecules25214983. PMC 7663239. PMID 33126458.
Wu X, Zhang Q, Guo J, Jia Y, Zhang Z, Zhao M, et al. (19 July 2017). "Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol". Frontiers in Pharmacology. 8 (479): 479. doi:10.3389/fphar.2017.00479. PMC 5515859. PMID 28769808.
Currens MJ, Mariner JM, McMahon JB, Boyd MR (November 1996). "Kinetic analysis of inhibition of human immunodeficiency virus type-1 reverse transcriptase by calanolide A". The Journal of Pharmacology and Experimental Therapeutics. 279 (2): 652–661. PMID 8930168.
Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT (March 2004). "Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis". Bioorganic & Medicinal Chemistry. 12 (5): 1199–1207. doi:10.1016/j.bmc.2003.11.012. PMID 14980631.
Creagh T, Ruckle JL, Tolbert DT, Giltner J, Eiznhamer DA, Dutta B, et al. (May 2001). "Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects". Antimicrobial Agents and Chemotherapy. 45 (5). American Society for microbiology: 1379–1386. doi:10.1128/AAC.45.5.1379-1386.2001. PMC 90477. PMID 11302799. Taken together, the above data demonstrate that the favorable safety profile, ...

ncbi.nlm.nih.gov

Nahar L, Talukdar AD, Nath D, Nath S, Mehan A, Ismail FM, Sarker SD (October 2020). "Naturally Occurring Calanolides: Occurrence, Biosynthesis, and Pharmacological Properties Including Therapeutic Potential". Molecules. 25 (21): 4983. doi:10.3390/molecules25214983. PMC 7663239. PMID 33126458.
Wu X, Zhang Q, Guo J, Jia Y, Zhang Z, Zhao M, et al. (19 July 2017). "Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol". Frontiers in Pharmacology. 8 (479): 479. doi:10.3389/fphar.2017.00479. PMC 5515859. PMID 28769808.
Creagh T, Ruckle JL, Tolbert DT, Giltner J, Eiznhamer DA, Dutta B, et al. (May 2001). "Safety and pharmacokinetics of single doses of (+)-calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects". Antimicrobial Agents and Chemotherapy. 45 (5). American Society for microbiology: 1379–1386. doi:10.1128/AAC.45.5.1379-1386.2001. PMC 90477. PMID 11302799. Taken together, the above data demonstrate that the favorable safety profile, ...

nova.my

Building Healthier Lives Together Annual Report 2019 (PDF). Noval Wellness Group. 2019. p. 14. Archived from the original (PDF) on 19 October 2021. Retrieved 5 October 2022. ... on behalf of Nova Laboratories for CRAUN Research Sdn Bhd, Sarawak ...

nytimes.com

Philip S (6 December 1994). "Hunt in Forests of Borneo Aims to Track Down Natural Drugs". New York Times. Archived from the original on 27 May 2018. Retrieved 27 May 2018. For its part, the provincial government of Sarawak, the Malaysian state where the Calophyllum trees were found, has banned logging of the species, a critical step given how much of the rain forests of Sarawak have already been ravaged by the timber industry.

sarawak.gov.my

forestry.sarawak.gov.my

"The Calophyllum story". Sarawak Forest Department. Archived from the original on 28 May 2018. Retrieved 27 May 2018.

sbc.org.my

"About Sarawak Biodiversity Centre – Profile". Sarawak Biodiversity Centre. Archived from the original on 6 December 2014. Retrieved 16 November 2015.

sec.gov

"Joint Venture Agreement Between Craun Research Sdn Bhd., Sarawak and Medichem Research Inc., USA". US Securities and Exchange Commission. December 1996. Archived from the original on 2017-05-26. Retrieved 5 October 2022.

theborneopost.com

Mail R (26 July 2019). "Researchers urged to step up game when conducting R&D". The Borneo Post. Archived from the original on 26 October 2019. Retrieved 26 October 2019.

thestar.com.my

"New milestone for anti-HIV drug". The Star (Malaysia). 26 November 2016. Archived from the original on 25 May 2018. Retrieved 25 May 2018.

web.archive.org

"The Calophyllum story". Sarawak Forest Department. Archived from the original on 28 May 2018. Retrieved 27 May 2018.
Ten KK, Wells A. Benefit-sharing case study - The access and benefit-sharing policies of the United States National Cancer Institute: a comparative account of the discovery and development of the drugs Calanolide and Topotecan (PDF). Convention of Biological Diversity. pp. 3–5. Archived from the original (PDF) on 8 December 2017. Retrieved 27 May 2018.
Philip S (6 December 1994). "Hunt in Forests of Borneo Aims to Track Down Natural Drugs". New York Times. Archived from the original on 27 May 2018. Retrieved 27 May 2018. For its part, the provincial government of Sarawak, the Malaysian state where the Calophyllum trees were found, has banned logging of the species, a critical step given how much of the rain forests of Sarawak have already been ravaged by the timber industry.
Parry RL (1 August 2001). "Bio-pirates raid trees in the swamps of Borneo". The Independent (UK). Archived from the original on 27 May 2018. Retrieved 27 May 2018.
"About Sarawak Biodiversity Centre – Profile". Sarawak Biodiversity Centre. Archived from the original on 6 December 2014. Retrieved 16 November 2015.
Ruff AM (14 June 2001). "From the jungle to the clinic". Borneo Resources Institute. Archived from the original on 15 August 2001. Retrieved 26 October 2019.
"Message From Our CEO". Craun Research Sdn Bhd. Archived from the original on 31 July 2017. Retrieved 27 May 2018.
"Joint Venture Agreement Between Craun Research Sdn Bhd., Sarawak and Medichem Research Inc., USA". US Securities and Exchange Commission. December 1996. Archived from the original on 2017-05-26. Retrieved 5 October 2022.
"Company Overview of Sarawak MediChem Pharmaceuticals Inc". Bloomberg. Archived from the original on 27 May 2018. Retrieved 27 May 2018.
"About Us - Calanolide A project". Archived from the original on 2 October 2022. Retrieved 2 October 2022.
Building Healthier Lives Together Annual Report 2019 (PDF). Noval Wellness Group. 2019. p. 14. Archived from the original (PDF) on 19 October 2021. Retrieved 5 October 2022. ... on behalf of Nova Laboratories for CRAUN Research Sdn Bhd, Sarawak ...
"New milestone for anti-HIV drug". The Star (Malaysia). 26 November 2016. Archived from the original on 25 May 2018. Retrieved 25 May 2018.
Mail R (26 July 2019). "Researchers urged to step up game when conducting R&D". The Borneo Post. Archived from the original on 26 October 2019. Retrieved 26 October 2019.

worldcat.org

search.worldcat.org

Jain MS, Barhate SD, Gayakwad BP (2018). "Calanolide A New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI): A Review". Asian Journal of Pharmaceutical Research. 8 (4): 241. doi:10.5958/2231-5691.2018.00041.2. ISSN 2231-5683.